Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
R-1,3-Butanediol (10G-A)
R-1,3-Butanediol (20G-A)
+2 more
Locations
1
United States
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
September 20, 2024
Primary Completion Date
October 1, 2027
Completion Date
October 1, 2027
Last Updated
September 4, 2025
NCT03050268
NCT05919264
NCT06950385
NCT06641310
NCT07133113
NCT06690970
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions